2017120 BioWorld

Dec 20th, 2017. Sensorion, Cochlear to evaluate drug-implant combo in hearing loss.
By Cormac Sheridan and Tamra Sami. Buy a reprint to read.

 Boursier.com : Interview of Nawal Ouzren, CEO Sensorion, Video (In French)

20171218 7 Les Echos

Les Echos.fr - 18/12/2017 - Article by Hubert Vialatte - READ (In French)

20171218 06 Biotec Finances

Sensorion  in the Biotech Finances newsletter - Read.

20171218 5 Biotech Santé

La Lettre M - Cochlear will invest around €1.6 million and receive an equity stake in Sensorion. Read (in French)

Latest news

  • 17 May 2019

    Sensorion announces oral presentation at the European Histamine Research Society. Read

  • 15 May 2019

    Sensorion announces the positive Data Safety Monitoring Board (DSMB) review and continuation of the phase 2 clinical trial for SENS-111 in acute unilateral vestibulopathy (AUV). 86 patients enrolled in SENS-111 clinical trial. Read

Key Opinion Leader Event

kol presentation 12 june

Treating Acute vertigo
New-York, June 12th, 2017


sensorion video simple

Novel approaches to treating 
Acute Unilateral Vestibulopathiy (AUV)

London, November 29, 2016